RosenbergB, Van CampL, KrigasT: Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature (London)205:698699, 1965.
2.
RozencweigM, Von HoffD, SlavikM, MuggiaF: Cis-diammine dichloroplatinum (II). A new anti-cancer drug. Ann Intern Med86:805812, 1977.
3.
RobertsJ, PascoeJ: Cross-linking of complementary strands of DNA in mammalian cells by antitumor platinum compounds. Nature235:282284, 1972.
4.
KleinermanE, ZwellingL, MuchmoreA: Enhancement of naturally occurring human spontaneous monocyte-mediated cytotoxicity by cis-diamminedichloroplatinum (II). Cancer Res40:30993102, 1980.
5.
ShapshayS, HongW, InczeJ, YamaguchiK, BhutaniR, VaughanC, StrongM: Histopathologic findings after cis-platinum bleomycin therapy in advanced previously untreated head and neck carcinoma. Am J Surg136:534538, 1978.
6.
LangeR, SpencerR, HarderH: The antitumor agent cis-Pt (NH3)2 Cl2: Distribution studies and dose calculations for 193mPt and 195mPt. J Nucl Med14:191195, 1973.
7.
DecontiR, ToftnessB, LangeR, CreaseyW: Clinical and pharmacological studies with cis-diamminedichloroplatinum (II). Cancer Res33:13101315, 1973.
8.
PielI, RayaduG, PerliaC, FriedmanA, FordhamE: Use of neutron activation analysis to study excretion of cis-diamminechloroplatinum (DDP) in cancer patients (abst). Proc Am Assoc Cancer Res/Proc Am Soc Clin Oncol15:111, 1974.
9.
HayesD, CvitrovicE, GolbeyR, ScheinerE, HelsonL, KrakoffI: High dose cis-platinum diammine dichloride: Amelioration of renal toxicity by mannitol diuresis. Cancer39:13721381, 1977.
10.
Von HoffD, SchilskyR, ReichertC, ReddickR, RozencweigM, YoungR, MaggiaF: Toxic effects of cis-dichlorodiammineplatinum (II) in man. Cancer Treat Rep63:15271531, 1979.
11.
ReddelR, KeffordR, GrantJ, CoatesA, FoxR, TattersallM: Ototoxicity in patients receiving cisplatin: Importance of dose and method of drug administration. Cancer Treat Rep66:1922, 1982.
12.
MeadG, JacobsC: Changing role of chemotherapy in treatment of head and neck cancer. Am J Med73:582595, 1982.
13.
PeppardSB, Al-SarrafM, PowersWE, LohJK, WeaverAW: Combination of cis-platinum, Oncovin, and bleomycin (COB) prior to surgery and/or radiotherapy in advanced untreated epidermoid cancer of the head and neck. Laryngoscope90:12731280, 1980.
14.
LesterE, JohnsonC, KemperA, BitmanJ, LanzottiV, GongolJ, MillerS, KiesS, MatzG: Cis-platinum, bleomycin and sequential methotrexate/5-fluoro-uracil for advanced squamous cell carcinoma of the head and neck.Abstract presented to American Society of Clinical Oncology, San Diego, May 1983.
15.
AmenM, Al-SarrafM, VaitkeviciusV: Factors that affect response to chemotherapy and survival of patients with advanced head and neck cancer. Cancer43:22022206, 1979.
16.
WeaverA, FlemingS, VandenburgH, DrelichmanA, JacobsJ, KinzieJ, LohJ, Al-SarrafM: Cis-platinum and 5-fluorouracil as initial therapy in advanced epidermoid cancers of the head and neck. Head Neck Surg4:370373, 1982.
17.
DeckerD, DrelichmanA, JacobsJ, HoschnerJ, KinzieJ, LohJ, WeaverA, Al-SarrafM: Adjuvant chemotherapy with cis-diamminechloroplatinum II and 120-hour infusion 5-fluorouracil in Stage III and IV squamous cell carcinoma of the head and neck. Cancer51:13531355, 1983.
